| Aurobindo Pharma Limited | 1,252 | 1,252G/0B | $0.6280 | -1.19% | 344↑ 684↓of 1028 | 2 | 18 |
| Sun Pharmaceutical Industries Inc. | 933 | 904G/29B | $3.0560 | -1.41% | 200↑ 361↓of 561 | 9 | 23 |
| NorthStar Rx LLC | 899 | 899G/0B | $1.6142 | -1.40% | 240↑ 603↓of 843 | 1 | 8 |
| Teva Pharmaceuticals USA Inc. | 812 | 795G/17B | $67.3279 | -1.05% | 279↑ 480↓of 759 | 4 | 13 |
| Rising Pharma Holdings Inc. | 764 | 763G/1B | $0.7296 | -1.44% | 217↑ 497↓of 714 | 1 | 7 |
| Major Pharmaceuticals | 734 | 734G/0B | $0.2821 | -1.00% | 215↑ 472↓of 687 | 24 | 7 |
| Dr. Reddy's Laboratories Inc. | 701 | 701G/0B | $2.2519 | -1.26% | 191↑ 380↓of 571 | 3 | 6 |
| Camber Pharmaceuticals Inc. | 668 | 668G/0B | $1.2549 | -1.44% | 208↑ 404↓of 612 | 1 | 7 |
| American Health Packaging | 639 | 638G/1B | $0.3631 | -1.09% | 182↑ 435↓of 617 | 32 | 2 |
| Mylan Pharmaceuticals Inc. | 628 | 623G/5B | $2.6917 | -1.26% | 192↑ 377↓of 569 | 8 | 9 |
| Zydus Pharmaceuticals (USA) Inc. | 625 | 618G/7B | $1.5731 | -1.59% | 157↑ 410↓of 567 | 2 | 9 |
| Lupin Pharmaceuticals Inc. | 557 | 552G/5B | $5.1341 | -1.56% | 123↑ 312↓of 435 | 2 | 14 |
| Alembic Pharmaceuticals Inc. | 523 | 523G/0B | $1.0053 | -1.50% | 171↑ 325↓of 496 | 2 | 2 |
| Chartwell RX LLC | 521 | 521G/0B | $0.5367 | -0.99% | 171↑ 328↓of 499 | 4 | 9 |
| Ascend Laboratories, LLC | 461 | 461G/0B | $1.1912 | -1.49% | 116↑ 287↓of 403 | — | 5 |
| Glenmark Pharmaceuticals Inc., USA | 444 | 444G/0B | $1.5714 | -1.28% | 114↑ 241↓of 355 | 1 | 8 |
| Actavis Pharma, Inc. | 439 | 438G/1B | $1.0660 | -1.12% | 131↑ 259↓of 390 | 1 | 11 |
| Strategic Sourcing Services LLC | 431 | 431G/0B | $0.2711 | +0.29% | 159↑ 146↓of 305 | 2 | 5 |
| Cardinal Health | 420 | 420G/0B | $0.1966 | +0.44% | 192↑ 143↓of 335 | 2 | 2 |
| Macleods Pharmaceuticals Limited | 418 | 418G/0B | $0.4752 | -1.98% | 115↑ 254↓of 369 | — | 1 |
| Hikma Pharmaceuticals USA Inc. | 414 | 414G/0B | $2.6289 | -0.41% | 136↑ 175↓of 311 | 2 | 3 |
| BluePoint Laboratories | 395 | 395G/0B | $2.8485 | -0.73% | 98↑ 242↓of 340 | 1 | 2 |
| Sandoz Inc. | 394 | 351G/43B | $22.2734 | -0.77% | 128↑ 181↓of 309 | 2 | 9 |
| AmerisourceBergen | 393 | 393G/0B | $0.3072 | +0.42% | 192↑ 141↓of 333 | — | 2 |
| Amneal Pharmaceuticals LLC | 388 | 359G/29B | $4.3578 | -1.14% | 100↑ 155↓of 255 | 2 | 15 |
| Solco Healthcare US LLC | 365 | 365G/0B | $0.2249 | -0.90% | 111↑ 236↓of 347 | 1 | 2 |
| Apotex Corp. | 362 | 350G/12B | $5.7148 | -1.92% | 90↑ 229↓of 319 | — | 9 |
| Heritage Pharmaceuticals Inc. | 317 | 317G/0B | $0.4668 | -0.77% | 93↑ 196↓of 289 | 2 | 8 |
| Accord Healthcare Inc. | 316 | 316G/0B | $0.7094 | -2.05% | 21↑ 74↓of 95 | 2 | 12 |
| Torrent Pharmaceuticals Limited | 315 | 315G/0B | $1.9140 | -1.19% | 81↑ 182↓of 263 | — | 2 |
| Cipla USA Inc. | 308 | 308G/0B | $1.6332 | -1.79% | 58↑ 148↓of 206 | 2 | 6 |
| Unichem Pharmaceuticals (USA) Inc. | 306 | 306G/0B | $0.1350 | -1.17% | 75↑ 207↓of 282 | — | 3 |
| Amneal Pharmaceuticals NY LLC | 306 | 306G/0B | $3.8371 | -1.95% | 81↑ 183↓of 264 | — | 7 |
| Upsher-Smith Laboratories LLC | 305 | 263G/42B | $3.1937 | -1.33% | 90↑ 146↓of 236 | — | 13 |
| AvPAK | 300 | 300G/0B | $0.2378 | -1.19% | 79↑ 214↓of 293 | 5 | 2 |
| ANI Pharmaceuticals, Inc. | 296 | 279G/17B | $3.1530 | -1.57% | 84↑ 179↓of 263 | 2 | 12 |
| Exelan Pharmaceuticals Inc. | 285 | 285G/0B | $0.2291 | -1.18% | 57↑ 205↓of 262 | — | — |
| Advagen Pharma Ltd. | 278 | 278G/0B | $0.4320 | -1.03% | 86↑ 191↓of 277 | — | 3 |
| Amneal Pharmaceuticals of New York LLC | 263 | 263G/0B | $3.1034 | -0.45% | 58↑ 91↓of 149 | — | 7 |
| Westminster Pharmaceuticals LLC | 263 | 263G/0B | $0.2887 | -2.09% | 63↑ 189↓of 252 | — | 1 |
| Padagis Israel Pharmaceuticals Ltd | 261 | 259G/2B | $3.3775 | -1.15% | 83↑ 161↓of 244 | — | 9 |
| Lannett Company Inc. | 258 | 258G/0B | $0.8051 | -1.24% | 69↑ 132↓of 201 | 2 | 5 |
| Strides Pharma Inc. | 247 | 247G/0B | $0.4402 | -1.15% | 71↑ 140↓of 211 | 2 | 3 |
| Epic Pharma LLC | 243 | 243G/0B | $0.4339 | -1.35% | 54↑ 146↓of 200 | 1 | 1 |
| Chain Drug Marketing Association | 227 | 227G/0B | $0.1222 | +0.43% | 68↑ 61↓of 129 | 4 | 4 |
| Endo USA Inc. | 219 | 204G/15B | $7.5217 | -1.45% | 72↑ 128↓of 200 | — | 8 |
| Granules Pharmaceuticals Inc. | 209 | 209G/0B | $0.6095 | -0.92% | 60↑ 137↓of 197 | — | 2 |
| Rugby Laboratories | 209 | 209G/0B | $0.4374 | +0.30% | 114↑ 75↓of 189 | 3 | 3 |
| Haleon US Holdings LLC | 203 | 0G/203B | $0.5315 | — | — | — | 8 |
| Ajanta Pharma USA Inc. | 194 | 194G/0B | $0.8641 | -1.60% | 53↑ 103↓of 156 | — | 5 |
| Novadoz Pharmaceuticals LLC | 191 | 191G/0B | $2.7353 | -2.65% | 38↑ 140↓of 178 | 3 | 2 |
| SpecGx LLC | 173 | 168G/5B | $1.6388 | -0.25% | 85↑ 70↓of 155 | — | 2 |
| L. Perrigo Company | 167 | 161G/6B | $0.2722 | +0.47% | 79↑ 78↓of 157 | — | 1 |
| Fresenius Kabi USA, LLC | 165 | 157G/8B | $24.6626 | +0.06% | 41↑ 54↓of 95 | — | 2 |
| Mylan Institutional LLC | 149 | 147G/2B | $25.1927 | -0.95% | 40↑ 83↓of 123 | 5 | 1 |
| Lifestar Pharma LLC | 148 | 148G/0B | $0.9564 | -1.99% | 25↑ 102↓of 127 | 2 | 1 |
| Quallent Pharmaceuticals Health LLC | 147 | 147G/0B | $4.5626 | -1.29% | 30↑ 117↓of 147 | 2 | 1 |
| Allergan, Inc. | 146 | 0G/146B | $40.6209 | +0.39% | 35↑ 35↓of 70 | — | 17 |
| Ingenus Pharmaceuticals LLC | 144 | 141G/3B | $3.6350 | -0.88% | 48↑ 78↓of 126 | 1 | 4 |
| Nivagen Pharmaceuticals Inc. | 137 | 137G/0B | $0.8604 | -0.84% | 20↑ 50↓of 70 | 2 | 5 |
| Viona Pharmaceuticals Inc. | 133 | 133G/0B | $0.5266 | -0.98% | 40↑ 91↓of 131 | — | 2 |
| Bionpharma Inc. | 131 | 131G/0B | $0.6396 | -0.36% | 53↑ 72↓of 125 | 2 | 2 |
| KVK-Tech Inc. | 130 | 130G/0B | $0.5263 | -0.11% | 45↑ 42↓of 87 | — | 4 |
| Cosette Pharmaceuticals, Inc. | 128 | 108G/20B | $4.1303 | -0.52% | 41↑ 70↓of 111 | — | 6 |
| Leading Pharma, LLC | 125 | 125G/0B | $0.8847 | -1.67% | 25↑ 77↓of 102 | 2 | 2 |
| ScieGen Pharmaceuticals, Inc. | 122 | 122G/0B | $0.1000 | -1.45% | 37↑ 82↓of 119 | — | 1 |
| Micro Labs Limited | 120 | 120G/0B | $0.6966 | -2.58% | 33↑ 68↓of 101 | 2 | 1 |
| Hospira Inc. | 119 | 117G/2B | $4.3266 | +0.30% | 24↑ 29↓of 53 | 2 | 3 |
| Jubilant Cadista Pharmaceuticals Inc. | 119 | 119G/0B | $0.2278 | -1.78% | 21↑ 43↓of 64 | — | 3 |
| Pfizer Inc. | 118 | 0G/118B | $62.6694 | -0.29% | 11↑ 40↓of 51 | — | 19 |
| RB Health (US) LLC | 110 | 0G/110B | $0.4154 | — | — | — | 4 |
| Method Pharmaceuticals LLC | 110 | 110G/0B | $0.2671 | -0.29% | 35↑ 57↓of 92 | — | 1 |
| Oceanside Pharmaceuticals | 108 | 108G/0B | $10.9894 | — | — | — | 4 |
| Bausch Health US LLC | 104 | 3G/101B | $34.0775 | — | — | — | 19 |
| Prasco Laboratories | 103 | 103G/0B | $15.6321 | -2.98% | 39↑ 60↓of 99 | — | 1 |
| Aurolife Pharma LLC | 99 | 99G/0B | $0.2477 | -1.05% | 26↑ 65↓of 91 | — | — |
| Taro Pharmaceuticals U.S.A. Inc. | 98 | 97G/1B | $0.8657 | -1.75% | 25↑ 39↓of 64 | — | 1 |
| Rhodes Pharmaceuticals L.P. | 97 | 83G/14B | $3.9866 | +0.43% | 41↑ 30↓of 71 | 1 | 1 |
| Viatris Specialty LLC | 95 | 4G/91B | $26.2244 | +0.22% | 25↑ 35↓of 60 | — | 21 |
| Slate Run Pharmaceuticals LLC | 94 | 94G/0B | $1.3508 | -1.58% | 12↑ 24↓of 36 | 1 | 2 |
| Alvogen Inc. | 94 | 94G/0B | $15.0664 | -1.78% | 30↑ 47↓of 77 | — | 2 |
| TruPharma LLC | 94 | 94G/0B | $1.0307 | -1.45% | 14↑ 65↓of 79 | — | 6 |
| Somerset Therapeutics, LLC | 93 | 93G/0B | $5.1791 | -2.05% | 30↑ 56↓of 86 | 1 | 1 |
| Biocon Pharma Inc. | 93 | 93G/0B | $2.4650 | -1.34% | 20↑ 65↓of 85 | — | 1 |
| Novartis Pharmaceuticals Corporation | 92 | 0G/92B | $762.12 | -0.01% | 18↑ 16↓of 34 | — | 15 |
| ScieGen Pharmaceuticals Inc. | 91 | 91G/0B | $0.2323 | -1.54% | 25↑ 65↓of 90 | — | — |
| Merck Sharp & Dohme LLC | 89 | 0G/89B | $84.7396 | +0.04% | 31↑ 9↓of 40 | — | 5 |
| Encube Ethicals, Inc. | 88 | 88G/0B | $0.9067 | -1.27% | 28↑ 57↓of 85 | — | — |
| AbbVie Inc. | 88 | 1G/87B | $1247.13 | -0.04% | 18↑ 41↓of 59 | — | 5 |
| Xiromed LLC | 88 | 88G/0B | $3.5860 | -0.71% | 32↑ 52↓of 84 | — | — |
| Time-Cap Labs Inc. | 86 | 86G/0B | $0.0777 | -0.03% | 31↑ 52↓of 83 | — | — |
| Bausch & Lomb Incorporated | 86 | 55G/31B | $21.5745 | -0.50% | 34↑ 23↓of 57 | 1 | 8 |
| Topco Associates LLC | 86 | 86G/0B | $0.3786 | — | — | 4 | 2 |
| Breckenridge Pharmaceutical Inc. | 85 | 85G/0B | $1.8701 | -0.34% | 35↑ 45↓of 80 | — | — |
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 82 | 82G/0B | $0.5524 | -1.38% | 21↑ 37↓of 58 | — | — |
| Oxford Pharmaceuticals, LLC | 82 | 82G/0B | $0.0741 | -1.52% | 16↑ 66↓of 82 | 1 | — |
| Takeda Pharmaceuticals America, Inc. | 80 | 1G/79B | $29.7730 | -0.09% | 15↑ 31↓of 46 | — | 14 |
| Mayne Pharma | 78 | 65G/13B | $33.6564 | +0.22% | 19↑ 21↓of 40 | 2 | 5 |
| Sagent Pharmaceuticals | 78 | 78G/0B | $6.6072 | -0.69% | 16↑ 27↓of 43 | — | — |
| Eli Lilly and Company | 77 | 4G/73B | $629.60 | -0.02% | 11↑ 25↓of 36 | — | 4 |
| Modavar Pharmaceuticals LLC | 75 | 75G/0B | $0.1453 | -0.96% | 25↑ 50↓of 75 | — | — |
| Boehringer Ingelheim Pharmaceuticals Inc. | 73 | 1G/72B | $69.6994 | +0.01% | 27↑ 31↓of 58 | — | 3 |
| Janssen Pharmaceuticals Inc. | 70 | 0G/70B | $581.06 | +0.05% | 17↑ 14↓of 31 | — | 5 |
| Padagis US LLC | 70 | 68G/2B | $7.6127 | -1.83% | 19↑ 40↓of 59 | — | 6 |
| Legacy Pharmaceutical Packaging, LLC | 68 | 68G/0B | $0.0453 | -0.51% | 17↑ 51↓of 68 | 3 | 2 |
| AstraZeneca Pharmaceuticals LP | 67 | 2G/65B | $38.5292 | -0.14% | 26↑ 16↓of 42 | — | 6 |
| GlaxoSmithKline LLC | 67 | 0G/67B | $34.6423 | +0.03% | 16↑ 18↓of 34 | — | 6 |
| Eugia US LLC | 67 | 67G/0B | $12.9477 | -1.03% | 16↑ 23↓of 39 | 1 | 1 |
| Meitheal Pharmaceuticals Inc. | 63 | 62G/1B | $23.1875 | -0.97% | 14↑ 27↓of 41 | — | — |
| Organon LLC | 62 | 1G/61B | $76.5365 | +0.06% | 17↑ 13↓of 30 | — | 14 |
| PAI Holdings LLC | 60 | 60G/0B | $4.2518 | +0.22% | 23↑ 25↓of 48 | 3 | 2 |
| PuraCap Laboratories LLC | 59 | 59G/0B | $0.6440 | -1.87% | 9↑ 38↓of 47 | 1 | — |
| Carlsbad Technology Inc. | 56 | 56G/0B | $0.1092 | -0.75% | 15↑ 35↓of 50 | — | — |
| Camber Consumer Care | 56 | 56G/0B | $0.1564 | +0.27% | 33↑ 20↓of 53 | — | — |
| Cranbury Pharmaceuticals, LLC | 56 | 56G/0B | $0.1695 | -0.70% | 18↑ 35↓of 53 | 1 | 1 |
| Novo Nordisk | 55 | 8G/47B | $182.06 | -0.01% | 6↑ 24↓of 30 | — | 1 |
| Pharmacia & Upjohn Company LLC | 55 | 0G/55B | $25.0424 | +0.24% | 18↑ 5↓of 23 | — | 10 |
| Sanofi-Aventis U.S. LLC | 54 | 17G/37B | $200.19 | -0.53% | 10↑ 16↓of 26 | — | 7 |
| Eywa Pharma Inc | 51 | 51G/0B | $0.4387 | -0.61% | 20↑ 15↓of 35 | — | — |
| McKesson | 50 | 50G/0B | $0.3401 | -1.07% | 10↑ 11↓of 21 | 3 | 1 |
| Laurus Labs Limited | 50 | 50G/0B | $0.3650 | -1.62% | 9↑ 37↓of 46 | — | — |
| Precision Dose Inc. | 48 | 48G/0B | $0.4003 | +0.13% | 20↑ 23↓of 43 | 1 | 1 |
| Alcon Laboratories, Inc. | 48 | 4G/44B | $12.1345 | +0.01% | 24↑ 15↓of 39 | — | 3 |
| Acella Pharmaceuticals, LLC | 48 | 48G/0B | $1.0382 | -1.40% | 19↑ 20↓of 39 | — | 2 |
| Florida Pharmaceutical Products, LLC | 48 | 48G/0B | $1.2450 | -2.35% | 17↑ 17↓of 34 | — | 1 |
| Bayer HealthCare LLC | 47 | 0G/47B | $0.5913 | — | — | — | 2 |
| Edenbridge Pharmaceuticals LLC | 46 | 46G/0B | $0.8495 | -2.03% | 10↑ 32↓of 42 | — | 1 |
| Elite Laboratories, Inc. | 46 | 46G/0B | $0.8283 | +0.31% | 28↑ 18↓of 46 | — | — |
| Trigen Laboratories, LLC | 45 | 45G/0B | $3.7679 | -2.78% | 15↑ 27↓of 42 | 1 | 2 |
| Quagen Pharmaceuticals LLC | 44 | 44G/0B | $0.3404 | -0.96% | 12↑ 29↓of 41 | — | — |
| Wilshire Pharmaceuticals Inc. | 42 | 42G/0B | $2.3486 | -1.32% | 20↑ 19↓of 39 | — | 1 |
| Par Health USA, LLC | 42 | 39G/3B | $3.8137 | +0.78% | 23↑ 14↓of 37 | — | 1 |
| Ohm Laboratories Inc. | 40 | 40G/0B | $0.2578 | -0.73% | 8↑ 26↓of 34 | — | 1 |
| Winder Laboratories LLC | 40 | 40G/0B | $0.9760 | -2.23% | 18↑ 19↓of 37 | — | — |
| Apnar Pharma LP | 37 | 37G/0B | $0.1410 | -0.47% | 14↑ 20↓of 34 | — | — |
| Mullan Pharmaceutical Inc. | 37 | 37G/0B | $1.7988 | -2.29% | 6↑ 30↓of 36 | — | — |
| UCB, Inc. | 37 | 0G/37B | $1007.76 | +0.02% | 11↑ 19↓of 30 | — | 3 |
| Sunrise Pharmaceutical Inc. | 37 | 37G/0B | $0.1789 | +0.79% | 19↑ 15↓of 34 | — | — |
| ACI Healthcare USA, Inc. | 36 | 36G/0B | $0.0612 | -0.93% | 6↑ 11↓of 17 | — | — |
| Baxter Healthcare Corporation | 35 | 35G/0B | $8.3833 | +0.86% | 8↑ 5↓of 13 | 1 | 1 |
| Vitruvias Therapeutics Inc. | 34 | 34G/0B | $2.4845 | -1.53% | 9↑ 21↓of 30 | — | — |
| Azurity Pharmaceuticals Inc. | 34 | 1G/33B | $5.7681 | -0.11% | 8↑ 7↓of 15 | 1 | 8 |
| Burel Pharmaceuticals, LLC | 33 | 33G/0B | $0.6444 | -1.00% | 12↑ 17↓of 29 | 1 | — |
| Amici Pharmaceuticals LLC | 32 | 32G/0B | $0.7282 | -1.11% | 6↑ 24↓of 30 | — | — |
| Amgen Inc. | 32 | 0G/32B | $875.44 | -0.06% | 4↑ 12↓of 16 | — | 1 |
| IBSA Pharma Inc. | 31 | 0G/31B | $5.3518 | — | — | — | 1 |
| Ritedose Pharmaceuticals, LLC | 30 | 30G/0B | $0.3360 | -1.29% | 11↑ 19↓of 30 | — | — |
| Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 30 | 0G/30B | $10.5404 | -0.03% | 14↑ 10↓of 24 | — | 3 |
| TAGI Pharma Inc. | 29 | 29G/0B | $0.2435 | — | — | 1 | 1 |
| Civica, Inc. | 28 | 28G/0B | $3.5081 | +2.46% | 10↑ 8↓of 18 | — | — |
| Bayer HealthCare Pharmaceuticals Inc. | 28 | 0G/28B | $45.3668 | -0.01% | 16↑ 8↓of 24 | — | 2 |
| Otsuka America Pharmaceutical Inc. | 27 | 0G/27B | $721.36 | -0.04% | 5↑ 13↓of 18 | — | 2 |
| Novitium Pharma LLC | 27 | 27G/0B | $0.5048 | -0.81% | 9↑ 17↓of 26 | — | 1 |
| SOLA Pharmaceuticals LLC | 26 | 26G/0B | $1.0155 | -1.24% | 11↑ 14↓of 25 | — | — |
| Atlantis Consumer Healthcare, Inc. | 26 | 3G/23B | $0.2210 | +0.03% | 5↑ 12↓of 17 | — | 1 |
| Sigmapharm Laboratories LLC | 26 | 26G/0B | $3.2089 | +1.04% | 17↑ 8↓of 25 | 1 | — |
| Purdue Pharma LP | 25 | 0G/25B | $35.6106 | +0.01% | 11↑ 8↓of 19 | — | 1 |
| Galderma Laboratories, L.P. | 25 | 0G/25B | $11.3999 | +0.05% | 3↑ 4↓of 7 | — | 8 |
| Nephron Pharmaceuticals Corporation | 24 | 23G/1B | $0.2628 | -0.28% | 9↑ 10↓of 19 | 1 | — |
| Fosun Pharma USA Inc. | 24 | 24G/0B | $9.2268 | -0.56% | 6↑ 13↓of 19 | — | — |
| Ipca Laboratories Limited | 24 | 24G/0B | $0.0782 | -1.57% | 5↑ 19↓of 24 | — | — |
| Pacific Pharma, Inc. | 24 | 24G/0B | $5.7917 | -1.49% | 8↑ 14↓of 22 | — | 1 |
| E.R. Squibb & Sons, L.L.C. | 24 | 0G/24B | $177.84 | +0.03% | 6↑ 7↓of 13 | — | 3 |
| Noven Therapeutics, LLC | 23 | 5G/18B | $17.1584 | +1.10% | 9↑ 6↓of 15 | — | — |
| H2-Pharma LLC | 22 | 10G/12B | $25.3689 | +1.41% | 6↑ 5↓of 11 | 1 | 2 |
| Caplin Steriles Limited | 22 | 22G/0B | $2.7071 | -0.37% | 6↑ 12↓of 18 | — | 1 |
| Genus Lifesciences Inc. | 22 | 19G/3B | $1.5572 | +0.49% | 12↑ 4↓of 16 | — | 3 |
| Aarna USA Inc. | 21 | 21G/0B | $0.1295 | -1.27% | 7↑ 14↓of 21 | — | — |
| Almatica Pharma LLC | 21 | 7G/14B | $10.7171 | -4.19% | 3↑ 10↓of 13 | — | 8 |
| Devatis Inc. | 20 | 20G/0B | $5.5903 | -9.29% | 2↑ 11↓of 13 | — | — |
| American Regent, Inc. | 20 | 17G/3B | $8.4872 | +0.80% | 6↑ 7↓of 13 | — | 2 |
| WG Critical Care, LLC | 19 | 19G/0B | $6.9908 | -1.98% | 1↑ 6↓of 7 | — | 1 |
| Amphastar Pharmaceuticals, Inc. | 19 | 17G/2B | $82.7841 | -1.01% | 5↑ 8↓of 13 | — | — |
| Yiling Pharmaceutical Inc. | 19 | 19G/0B | $0.1560 | — | — | — | — |
| The Procter & Gamble Manufacturing Company | 18 | 0G/18B | $0.2947 | — | — | — | — |
| Astellas Pharma US, Inc. | 18 | 0G/18B | $17.5070 | -0.06% | 4↑ 4↓of 8 | — | 2 |
| Gilead Sciences, Inc. | 18 | 0G/18B | $285.92 | -0.01% | 5↑ 3↓of 8 | — | 2 |
| Oryza Pharmaceuticals Inc. | 18 | 18G/0B | $0.1363 | +1.65% | 9↑ 9↓of 18 | — | — |
| Neolpharma, Inc. | 17 | 17G/0B | $0.0581 | -2.18% | 2↑ 15↓of 17 | — | — |
| Reliable 1 Laboratories LLC | 17 | 17G/0B | $0.0268 | — | — | — | — |
| Vertical Pharmaceuticals, LLC | 17 | 3G/14B | $8.2888 | -0.02% | 1↑ 2↓of 3 | — | 2 |
| Amici Pharma, Inc | 16 | 16G/0B | $0.5103 | +3.28% | 11↑ 5↓of 16 | — | — |
| Tris Pharma Inc | 16 | 16G/0B | $0.3734 | -5.92% | 1↑ 5↓of 6 | — | 1 |
| Teva Neuroscience, Inc. | 16 | 0G/16B | $244.96 | -0.03% | 4↑ 6↓of 10 | — | 1 |
| Vensun Pharmaceuticals, Inc. | 15 | 15G/0B | $0.0549 | — | — | — | — |
| Seton Pharmaceuticals | 15 | 15G/0B | $21.3656 | -1.94% | 3↑ 6↓of 9 | — | — |
| Sumitomo Pharma America, Inc. | 15 | 0G/15B | $42.4785 | -0.06% | 2↑ 4↓of 6 | — | 2 |
| e5 Pharma, LLC | 15 | 15G/0B | $0.5679 | -5.93% | 3↑ 12↓of 15 | — | — |
| Eisai Inc. | 15 | 0G/15B | $22.1033 | -0.01% | 2↑ 7↓of 9 | — | 2 |
| Xellia Pharmaceuticals USA LLC | 15 | 15G/0B | $11.9601 | -2.99% | 0↑ 2↓of 2 | — | — |
| Genentech, Inc. | 15 | 0G/15B | $196.52 | -0.07% | 0↑ 6↓of 6 | — | 2 |
| Bausch & Lomb Americas Inc. | 15 | 15G/0B | $12.7696 | -3.70% | 5↑ 10↓of 15 | — | 1 |
| B. Braun Medical Inc. | 15 | 15G/0B | $0.0047 | -3.03% | 0↑ 3↓of 3 | — | — |
| Natco Pharma USA LLC | 15 | 15G/0B | $0.3142 | -1.88% | 3↑ 10↓of 13 | — | — |
| Neos Therapeutics Brands, LLC | 15 | 6G/9B | $16.7718 | -0.29% | 3↑ 9↓of 12 | — | 1 |
| Armas Pharmaceuticals Inc. | 15 | 15G/0B | $1.6483 | -2.78% | 2↑ 7↓of 9 | 1 | 1 |
| Trifluent Pharma LLC | 15 | 15G/0B | $6.2762 | +2.98% | 8↑ 5↓of 13 | — | 2 |
| Salix Pharmaceuticals Inc. | 15 | 0G/15B | $105.14 | — | — | — | 1 |
| Supernus Pharmaceuticals Inc. | 15 | 0G/15B | $19.9250 | -0.12% | 2↑ 8↓of 10 | — | 1 |
| Solaris Pharma Corporation | 14 | 14G/0B | $2.1399 | -1.72% | 6↑ 8↓of 14 | — | — |
| Xttrium Laboratories, Inc. | 14 | 10G/4B | $0.0437 | -1.30% | 5↑ 6↓of 11 | — | — |
| YARAL Pharma Inc. | 14 | 14G/0B | $2.6555 | — | — | — | — |
| Archis Pharma LLC | 14 | 14G/0B | $0.7725 | -3.97% | 3↑ 11↓of 14 | — | — |
| Saptalis Pharmaceuticals LLC | 13 | 11G/2B | $0.9728 | +2.19% | 8↑ 4↓of 12 | — | 1 |
| Provell Pharmaceuticals, LLC | 13 | 0G/13B | $0.1719 | — | — | — | — |
| Janssen Products LP | 13 | 0G/13B | $190.30 | +0.02% | 3↑ 3↓of 6 | — | 2 |
| Llorens Pharmaceutical International Division | 13 | 13G/0B | $0.0987 | -1.65% | 1↑ 4↓of 5 | — | — |
| BE Pharmaceuticals Inc. | 13 | 13G/0B | $10.7936 | -0.93% | 3↑ 5↓of 8 | — | — |
| ViiV Healthcare Company | 13 | 0G/13B | $60.6405 | +0.08% | 3↑ 2↓of 5 | — | 3 |
| NextWave Pharmaceuticals, Inc | 13 | 0G/13B | $8.9357 | — | 4↑ 6↓of 10 | — | 1 |
| Pharbest Pharmaceuticals, Inc. | 13 | 13G/0B | $0.0255 | — | — | — | — |
| Innogenix, Inc. | 13 | 13G/0B | $0.1626 | — | — | — | — |
| USAntibiotics, LLC | 13 | 13G/0B | $0.1743 | -1.93% | 3↑ 10↓of 13 | — | — |
| Collegium Pharmaceutical, Inc. | 13 | 0G/13B | $17.5109 | — | — | — | — |
| Afaxys Pharma, LLC | 13 | 13G/0B | $0.6184 | -0.22% | 6↑ 7↓of 13 | — | — |
| Patrin Pharma Inc. | 12 | 12G/0B | $0.4484 | -1.25% | 3↑ 7↓of 10 | 1 | 1 |
| Mission Pharmacal Company | 12 | 2G/10B | $4.3325 | -0.68% | 0↑ 3↓of 3 | — | 3 |
| Nordic Pharma, Inc. | 12 | 12G/0B | $6.0992 | -0.34% | 8↑ 4↓of 12 | — | — |
| i3 Pharmaceuticals, LLC | 12 | 12G/0B | $1.9353 | -3.14% | 4↑ 7↓of 11 | — | — |
| Roerig | 12 | 0G/12B | $23.1351 | +0.20% | 3↑ 2↓of 5 | — | 3 |
| Poly Pharmaceuticals, Inc. | 11 | 11G/0B | $0.5261 | -0.86% | 0↑ 1↓of 1 | — | — |
| C.B. Fleet Company, Inc. | 11 | 0G/11B | $0.0996 | — | — | — | 2 |
| Zameer Pharmaceuticals LLC | 11 | 11G/0B | $0.6960 | -1.58% | 1↑ 1↓of 2 | — | 3 |
| Crown Laboratories | 11 | 9G/2B | $0.2542 | — | — | — | 1 |
| CarWin Pharmaceutical Associates LLC | 11 | 2G/9B | $14.9613 | +18.43% | 2↑ 0↓of 2 | — | 3 |
| Larken Laboratories, Inc. | 11 | 11G/0B | $0.2139 | -0.66% | 5↑ 4↓of 9 | — | — |
| Edwards Pharmaceuticals, Inc. | 11 | 10G/1B | $0.8752 | +1.78% | 5↑ 2↓of 7 | — | — |
| Arbor Pharmaceuticals, Inc. | 11 | 11G/0B | $3.6730 | +2.82% | 3↑ 1↓of 4 | — | — |
| Novugen Pharma (USA) LLC | 11 | 11G/0B | $0.6828 | -1.48% | 1↑ 10↓of 11 | — | — |
| TWi Pharmaceuticals, Inc. | 11 | 11G/0B | $0.1415 | -1.36% | 4↑ 7↓of 11 | — | — |
| Aimmune Therapeutics, Inc. | 10 | 0G/10B | $8.5819 | +0.11% | 8↑ 1↓of 9 | — | — |
| Cambridge Therapeutics Technologies, LLC | 10 | 10G/0B | $0.2930 | — | — | — | 1 |
| Teva Parenteral Medicines, Inc. | 10 | 10G/0B | $2.7824 | -2.13% | 2↑ 4↓of 6 | — | 1 |
| Exeltis USA, Inc. | 10 | 0G/10B | $7.7800 | +0.01% | 2↑ 4↓of 6 | — | 1 |
| VistaPharm, LLC | 10 | 10G/0B | $0.8557 | -0.25% | 3↑ 5↓of 8 | 1 | 1 |
| Alkermes, Inc. | 10 | 0G/10B | $695.24 | +0.18% | 6↑ 3↓of 9 | — | — |
| Currax Pharmaceuticals LLC | 10 | 3G/7B | $24.6196 | — | — | — | 1 |
| Janssen Biotech, Inc. | 10 | 0G/10B | $13112.60 | -0.18% | 0↑ 1↓of 1 | — | 1 |
| CivicaScript LLC | 10 | 10G/0B | $0.8108 | -7.00% | 1↑ 8↓of 9 | — | — |
| SK Life Science, Inc. | 10 | 0G/10B | $35.2922 | +0.03% | 4↑ 6↓of 10 | — | — |
| Hepalink USA Inc. | 10 | 10G/0B | $7.3440 | -1.00% | 3↑ 6↓of 9 | — | — |
| Sheffield Pharmaceuticals LLC | 10 | 10G/0B | $0.1009 | -0.62% | 4↑ 6↓of 10 | — | — |
| EMD Serono, Inc. | 9 | 0G/9B | $1430.03 | -0.07% | 0↑ 1↓of 1 | — | — |
| Apozeal Pharmaceuticals Inc. | 9 | 9G/0B | $0.0449 | -0.78% | 4↑ 5↓of 9 | — | — |
| Axsome Therapeutics, Inc. | 9 | 0G/9B | $38.1413 | +0.19% | 2↑ 1↓of 3 | — | — |
| Carnegie Pharmaceuticals LLC | 9 | 7G/2B | $1.3138 | -2.30% | 1↑ 6↓of 7 | — | — |
| International Medication Systems, Limited | 9 | 9G/0B | $5.1486 | +1.10% | 4↑ 2↓of 6 | — | 1 |
| Virtus Pharmaceuticals, LLC | 9 | 9G/0B | $2.2334 | -0.76% | 2↑ 5↓of 7 | — | 2 |
| Person and Covey | 9 | 4G/5B | $0.0994 | -0.15% | 0↑ 2↓of 2 | — | — |
| XGen Pharmaceuticals DJB, Inc. | 9 | 9G/0B | $10.8237 | +1.50% | 3↑ 1↓of 4 | — | — |
| Nomax Inc. | 9 | 9G/0B | $0.4173 | -0.28% | 2↑ 7↓of 9 | — | — |
| Antares Pharma, Inc. | 9 | 0G/9B | $325.24 | +0.06% | 1↑ 3↓of 4 | — | 1 |
| Avet Pharmaceuticals Inc. | 9 | 9G/0B | $0.9196 | -1.61% | 3↑ 5↓of 8 | — | — |
| CMP Pharma, Inc. | 9 | 5G/4B | $2.4363 | -0.17% | 3↑ 3↓of 6 | 1 | 1 |
| Avion Pharmaceuticals, LLC | 9 | 0G/9B | $8.4268 | — | — | — | 1 |
| ARMAS PHARMACEUTICALS INC. | 9 | 9G/0B | $8.6082 | -0.77% | 3↑ 5↓of 8 | — | 1 |
| Gabar Health Sciences Corp. | 8 | 8G/0B | $0.2666 | — | — | 1 | — |
| Medimetriks Pharmaceuticals Inc. | 8 | 4G/4B | $40.7897 | -5.17% | 0↑ 4↓of 4 | — | 4 |
| Cephalon, LLC | 8 | 0G/8B | $47.2154 | +0.04% | 2↑ 1↓of 3 | — | 2 |
| Neurelis, Inc | 8 | 0G/8B | $366.19 | +0.01% | 1↑ 3↓of 4 | — | — |
| Avenacy Inc. | 8 | 8G/0B | $30.7048 | -0.19% | 4↑ 2↓of 6 | — | — |
| BioDelivery Sciences International Inc | 8 | 0G/8B | $14.1522 | +0.03% | 4↑ 4↓of 8 | — | — |
| Omnivium Pharmaceuticals LLC | 8 | 8G/0B | $1.9575 | +0.70% | 5↑ 1↓of 6 | — | 2 |
| Harrow Eye, LLC | 8 | 0G/8B | $90.0603 | +0.09% | 4↑ 3↓of 7 | — | 2 |
| Validus Pharmaceuticals LLC | 8 | 0G/8B | $2.5623 | -0.18% | 0↑ 5↓of 5 | — | 3 |
| Ferring Pharmaceuticals Inc. | 8 | 1G/7B | $167.35 | -0.21% | 0↑ 2↓of 2 | — | 1 |
| Teva Respiratory, LLC | 8 | 0G/8B | $131.25 | +0.03% | 2↑ 2↓of 4 | — | 2 |
| Medexus Pharma Inc. | 7 | 0G/7B | $542.66 | — | — | — | 1 |
| Fougera Pharmaceuticals Inc. | 7 | 7G/0B | $2.0288 | +0.04% | 3↑ 2↓of 5 | — | — |
| Catalyst Pharmaceuticals, Inc. | 7 | 0G/7B | $31.4071 | -0.03% | 0↑ 6↓of 6 | — | — |
| Indivior Inc. | 7 | 0G/7B | $704.94 | +0.05% | 3↑ 2↓of 5 | — | 1 |
| OWP Pharmaceuticals, Inc. | 7 | 7G/0B | $4.1568 | -0.11% | 3↑ 2↓of 5 | — | 1 |
| Daiichi Sankyo Inc. | 7 | 0G/7B | $14.3754 | +0.05% | 1↑ 0↓of 1 | — | 1 |
| Advanz Pharma (US) Corp. | 7 | 0G/7B | $12.8504 | — | — | — | 3 |
| U.S. Pharmaceutical Corporation | 7 | 0G/7B | $0.7321 | -0.01% | 1↑ 1↓of 2 | — | — |
| Sebela Pharmaceuticals Inc. | 7 | 0G/7B | $21.1091 | +0.05% | 1↑ 0↓of 1 | — | 1 |
| Santarus Inc. | 7 | 0G/7B | $81.9991 | — | — | — | 3 |
| Vanda Pharmaceuticals Inc. | 7 | 0G/7B | $41.0438 | — | — | — | — |
| Digestive Care, Inc. | 6 | 0G/6B | $5.3480 | +0.21% | 2↑ 0↓of 2 | — | — |
| Melinta Therapeutics, LLC | 6 | 0G/6B | $25.4008 | +0.03% | 3↑ 0↓of 3 | — | 1 |
| Mannkind Corporation | 6 | 0G/6B | $10.4102 | — | — | — | — |
| PureTek Corporation | 6 | 6G/0B | $0.8989 | +1.17% | 1↑ 1↓of 2 | — | — |
| Foundation Consumer Healthcare LLC | 6 | 4G/2B | $14.6070 | — | — | — | 1 |
| Thea Pharma Inc. | 6 | 0G/6B | $29.1007 | — | 2↑ 2↓of 4 | — | 3 |
| Xeris Pharmaceuticals, Inc. | 6 | 0G/6B | $1868.04 | — | — | — | — |
| Hisun Pharmaceuticals USA Inc. | 6 | 6G/0B | $1.6036 | -0.65% | 2↑ 2↓of 4 | 1 | — |
| BioComp Pharma Inc. | 6 | 6G/0B | $0.9709 | -0.66% | 2↑ 3↓of 5 | — | — |
| Orexo US, Inc. | 6 | 0G/6B | $11.4120 | +0.03% | 2↑ 4↓of 6 | — | — |
| Vivus LLC | 6 | 0G/6B | $5.2303 | — | — | — | — |
| Kesin Pharma Corporation | 6 | 5G/1B | $0.6265 | -0.27% | 2↑ 2↓of 4 | — | — |
| Allegis Pharmaceuticals, LLC | 6 | 6G/0B | $7.2939 | -0.35% | 3↑ 2↓of 5 | — | — |
| INA Pharmaceutics Inc | 5 | 4G/1B | $8.8575 | +12.25% | 2↑ 1↓of 3 | — | 1 |
| Coloplast Manufacturing US, LLC | 5 | 4G/1B | $0.0663 | — | — | — | — |
| Covis Pharma US, Inc | 5 | 0G/5B | $27.6074 | -0.12% | 0↑ 3↓of 3 | — | 1 |
| Brookfield Pharmaceuticals, LLC | 5 | 5G/0B | $0.4933 | — | — | — | — |
| Hikma Specialty USA Inc. | 5 | 0G/5B | $17.1030 | +0.04% | 3↑ 1↓of 4 | — | 1 |
| Biocon Biologics Inc. | 5 | 2G/3B | $649.95 | +0.09% | 2↑ 1↓of 3 | — | — |
| Ironshore Pharmaceuticals Inc. | 5 | 0G/5B | $15.4100 | -0.03% | 1↑ 3↓of 4 | — | 1 |
| LEO Pharma Inc. | 5 | 0G/5B | $17.6603 | +0.04% | 2↑ 0↓of 2 | — | 2 |
| Leadiant Biosciences, Inc. | 5 | 0G/5B | $0.6160 | — | — | — | — |
| Oliva Therapeutics, LLC | 5 | 4G/1B | $0.3896 | +4.32% | 4↑ 0↓of 4 | — | — |
| Patriot Pharmaceuticals | 5 | 5G/0B | $14.1866 | +0.09% | 1↑ 1↓of 2 | — | 1 |
| Pharmaceutical Associates, Inc. | 5 | 5G/0B | $0.1823 | +0.95% | 1↑ 1↓of 2 | — | — |
| Provepharm Inc. | 5 | 5G/0B | $24.9727 | -0.94% | 0↑ 2↓of 2 | — | — |
| Rising Health, LLC | 5 | 5G/0B | $0.0871 | -0.89% | 3↑ 2↓of 5 | — | — |
| The J. Molner Company LLC | 5 | 5G/0B | $0.5731 | -7.66% | 2↑ 2↓of 4 | — | — |
| VGYAAN Pharmaceuticals LLC | 5 | 5G/0B | $52.5722 | -6.33% | 0↑ 1↓of 1 | — | 2 |
| Immunex Corporation | 4 | 0G/4B | $2080.11 | -0.09% | 0↑ 2↓of 2 | — | — |
| Hillestad Pharmaceuticals USA | 4 | 4G/0B | $0.2453 | -1.18% | 0↑ 2↓of 2 | — | — |
| Oncor Pharmaceuticals | 4 | 4G/0B | $0.1315 | -4.13% | 0↑ 4↓of 4 | — | — |
| Acertis Pharmaceuticals, LLC | 4 | 2G/2B | $15.0454 | +0.39% | 1↑ 2↓of 3 | — | 2 |
| Braintree Laboratories, Inc. | 4 | 0G/4B | $17.1790 | -0.01% | 2↑ 2↓of 4 | — | — |
| Aprecia Pharmaceuticals, LLC | 4 | 0G/4B | $10.2726 | — | — | — | 1 |
| Medicure International Inc | 4 | 0G/4B | $7.4211 | +0.01% | 2↑ 2↓of 4 | — | — |
| GenBioPro, Inc. | 4 | 4G/0B | $0.7207 | +5.98% | 3↑ 0↓of 3 | — | — |
| Quinn Pharmaceuticals | 4 | 4G/0B | $0.1644 | -4.13% | 0↑ 4↓of 4 | — | — |
| GM Pharmaceuticals, INC | 4 | 1G/3B | $0.1821 | +0.56% | 1↑ 0↓of 1 | — | — |
| Fresenius Kabi, LLC | 4 | 4G/0B | $4.4165 | — | — | — | — |
| Phathom Pharmaceuticals Inc. | 4 | 0G/4B | $14.9615 | -0.07% | 1↑ 1↓of 2 | — | — |
| TOLMAR Inc. | 4 | 1G/3B | $8.9767 | -0.36% | 1↑ 3↓of 4 | — | — |
| Vista Pharmaceuticals, Inc. | 4 | 4G/0B | $0.0788 | — | — | — | 1 |
| Duchesnay USA, Inc. | 4 | 0G/4B | $7.2876 | — | 2↑ 1↓of 3 | — | 1 |
| Cameron Pharmaceuticals | 4 | 4G/0B | $1.3686 | -0.73% | 2↑ 2↓of 4 | — | — |
| Dista Products Company | 4 | 0G/4B | $16.4383 | — | — | — | 1 |
| Beach Products, Inc. | 4 | 4G/0B | $0.4190 | -1.42% | 0↑ 4↓of 4 | — | — |
| ACI Healthcare USA Inc. | 4 | 4G/0B | $0.0364 | -0.22% | 1↑ 1↓of 2 | — | — |
| SDA Laboratories, Inc. | 4 | 4G/0B | $0.0285 | — | — | — | — |
| Marnel Pharmaceuticals, Inc. | 3 | 3G/0B | $2.2079 | — | — | — | — |
| BF ASCHER AND CO INC | 3 | 1G/2B | $0.0589 | — | — | — | — |
| Lundbeck Pharmaceuticals LLC | 3 | 0G/3B | $34.1107 | +0.05% | 1↑ 0↓of 1 | — | 1 |
| Long Grove Pharmaceuticals, LLC | 3 | 3G/0B | $5.4864 | -1.51% | 1↑ 2↓of 3 | — | — |
| Vifor Pharma, Inc. | 3 | 0G/3B | $37.8214 | +0.02% | 2↑ 1↓of 3 | — | — |
| Lifsa Drugs LLC | 3 | 3G/0B | $9.8926 | -0.65% | 0↑ 1↓of 1 | — | 1 |
| Lexicon Pharmaceuticals, Inc. | 3 | 0G/3B | $20.2451 | — | — | — | — |
| Laser Pharmaceuticals, LLC | 3 | 3G/0B | $1.0092 | — | — | — | 1 |
| Intra-Cellular Therapies, Inc | 3 | 0G/3B | $57.2738 | -0.05% | 0↑ 1↓of 1 | — | — |
| WOMENS CHOICE PHARMACEUTICALS LLC | 3 | 1G/2B | $3.1567 | — | — | — | — |
| West-Ward Pharmaceuticals Corp | 3 | 3G/0B | $0.2997 | — | — | — | 1 |
| Greenstone LLC | 3 | 3G/0B | $0.9055 | -3.32% | 0↑ 3↓of 3 | — | — |
| Genzyme Corporation | 3 | 0G/3B | $13.3447 | — | — | — | 1 |
| GRIFOLS USA, LLC | 3 | 0G/3B | $3.5465 | — | — | — | — |
| ALK-Abello A S | 3 | 0G/3B | $11.7205 | -0.01% | 1↑ 1↓of 2 | — | — |
| CIMA LABS INC. | 3 | 3G/0B | $0.3176 | +1.18% | 2↑ 1↓of 3 | — | — |
| Cumberland Pharmaceuticals Inc. | 3 | 0G/3B | $236.12 | +0.16% | 1↑ 0↓of 1 | — | — |
| Savage Laboratories a division of Fougera Pharmaceuticals Inc. | 3 | 0G/3B | $1.6275 | -0.08% | 0↑ 2↓of 2 | — | — |
| CDMA | 3 | 3G/0B | $0.0136 | +1.64% | 3↑ 0↓of 3 | — | — |
| Royal Pharmaceuticals | 3 | 0G/3B | $0.5386 | — | — | — | — |
| RedHill Biopharma Ltd | 3 | 0G/3B | $11.3692 | +0.09% | 1↑ 0↓of 1 | — | — |
| Aquestive Therapeutics | 3 | 0G/3B | $38.1963 | — | — | — | 1 |
| Affordable Pharmaceuticals, LLC | 3 | 3G/0B | $0.0385 | -1.59% | 0↑ 3↓of 3 | — | — |
| Quest Products, LLC | 3 | 0G/3B | $0.3756 | +0.58% | 1↑ 0↓of 1 | — | 1 |
| Teva Women's Health, Inc. | 3 | 0G/3B | $36.1691 | -0.40% | 0↑ 1↓of 1 | — | 1 |
| Capital Pharma | 3 | 0G/3B | $0.2381 | — | — | — | — |
| Puro Pharma Inc. | 3 | 3G/0B | $0.9461 | -0.09% | 2↑ 1↓of 3 | — | 1 |
| Piramal Critical Care | 3 | 3G/0B | $1.3651 | +3.22% | 1↑ 0↓of 1 | — | — |
| kaleo, Inc | 3 | 0G/3B | $297.68 | -0.02% | 0↑ 2↓of 2 | — | — |
| Phlow Corporation | 3 | 3G/0B | $0.4954 | -1.09% | 1↑ 1↓of 2 | — | — |
| Arcutis Biotherapeutics, Inc. | 3 | 0G/3B | $15.3857 | +0.08% | 3↑ 0↓of 3 | — | 1 |
| OPKO Pharmaceuticals LLC | 3 | 0G/3B | $40.4576 | +0.17% | 1↑ 0↓of 1 | — | — |
| Aucta Pharmaceuticals, Inc. | 3 | 0G/3B | $21.2735 | -0.03% | 0↑ 1↓of 1 | — | 1 |
| Neurocrine Biosciences, Inc. | 3 | 0G/3B | $275.20 | — | — | — | — |
| Millicent US, Inc. | 3 | 0G/3B | $602.37 | -0.13% | 0↑ 3↓of 3 | — | — |
| Adare Pharmaceuticals Inc | 3 | 3G/0B | $0.1265 | — | — | — | — |
| Corium, LLC. | 3 | 0G/3B | $14.4186 | -0.02% | 1↑ 2↓of 3 | — | — |
| Valinor Pharma, LLC | 3 | 0G/3B | $14.6107 | — | — | — | — |